Edistride

Edistride

Manufacturer:

AstraZeneca
Concise Prescribing Info
Contents
Dapagliflozin

Information is sourced from publicly available references. The information is for educational purpose of healthcare professionals and we are not liable for any loss or damage.
Indications/Uses
Improve glycemic control as an adjunct to diet & exercise in adults w/ type 2 DM as monotherapy or in combination w/ other medicinal products. Reduce risk of CV death & hospitalization for heart failure in adults w/ heart failure (NYHA class II-IV). Adjunct to standard therapy to reduce the risk of sustained eGFR decline, ESRD & CV death in adults w/ CKD at risk of progression.
Dosage/Direction for Use
Recommended dose: 10 mg once daily at any time of the day.
Administration
May be taken with or without food. Take regardless of meals.
Contraindications
Hypersensitivity.
MIMS Class
Antidiabetic Agents
ATC Classification
A10BK01 - dapagliflozin ; Belongs to the class of sodium-glucose co-transporter 2 (SGLT2) inhibitors. Used in the treatment of diabetes.
Presentation/Packing
Form
Edistride FC tab 10 mg
Packing/Price
1's
Advertisement
Advertisement
Advertisement
Advertisement
Advertisement
Advertisement